The Claim
In mice treated with semaglutide, inhibition of 15-PGDH results in approximately 30% greater retention of lean body mass compared to untreated controls.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice given semaglutide, blocking the enzyme 15-PGDH leads to 30% more preservation of lean body mass than in mice not given any treatment.
See the scientific wording
In mice on semaglutide, inhibition of 15-PGDH results in approximately 30% greater retention of lean body mass compared to untreated controls.
When the body is in a low-nutrient state, muscle stem cells stop dividing and cannot repair damaged muscle fibers. Blocking the enzyme that breaks down PGE2 allows PGE2 to build up, which activates receptors on muscle stem cells. This triggers a chain reaction inside the cells that turns on genes needed for them to multiply. More muscle stem cells divide and become new muscle fibers, which prevents muscle loss even when nutrients are scarce.
What the research says
2 studiesWhen mice on semaglutide (a weight-loss drug) lost muscle, blocking a specific enzyme (15-PGDH) helped their muscles recover almost fully — by about 30%, just like the claim said.
When mice on semaglutide (a weight-loss drug) were given a second drug that blocks 15-PGDH, their muscles recovered much better after injury — about 30–40% more than with semaglutide alone. This means the second drug helped keep their muscles stronger and healthier, even while losing weight.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.